These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6102457)

  • 21. Binding kinetics of quinuclidinyl benzilate and methyl-quinuclidinyl benzilate enantiomers at neuronal (M1), cardiac (M2), and pancreatic (M3) muscarinic receptors.
    Waelbroeck M; Tastenoy M; Camus J; Christophe J
    Mol Pharmacol; 1991 Sep; 40(3):413-20. PubMed ID: 1896027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of direct competition for, and indirect influences on, striatal muscarinic cholinergic receptors: in vivo [3H]quinuclidinyl benzilate binding in rats.
    Pelham RW; Munsat TL
    Brain Res; 1979 Aug; 171(3):473-80. PubMed ID: 476482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Plasma anticholinergic activity and cognitive function in geriatric patients].
    Thienhaus OJ; Thoene J; Allen A; Zemlan FP
    Psychiatr Neurol Med Psychol (Leipz); 1990 May; 42(5):275-81. PubMed ID: 1975100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tricyclic antidepressant radioreceptor assay.
    Innis RB; Tune L; Rock R; Depaulo R; U'Prichard DC; Snyder SH
    Eur J Pharmacol; 1979 Oct; 58(4):473-7. PubMed ID: 510379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biperiden and haloperidol plasma levels and extrapyramidal side effects in schizophrenic patients.
    Meszaros K; Lenzinger E; Hornik K; Schönbeck G; Hatzinger R; Langer G; Sieghart W; Aschauer HN
    Neuropsychobiology; 1997; 36(2):69-72. PubMed ID: 9267855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [3H]Pirenzepine and [3H]quinuclidinyl benzilate binding to brain muscarinic cholinergic receptors. Differences in measured receptor density are not explained by differences in receptor isomerization.
    Luthin GR; Wolfe BB
    Mol Pharmacol; 1984 Sep; 26(2):164-9. PubMed ID: 6548291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anticholinergic activity in the serum of patients receiving maintenance disopyramide therapy.
    Iisalo E; Aaltonen L
    Br J Clin Pharmacol; 1984 Mar; 17(3):325-9. PubMed ID: 6712865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on muscarinic binding sites in human brain identified with [3H]pirenzepine.
    Lin SC; Olson KC; Okazaki H; Richelson E
    J Neurochem; 1986 Jan; 46(1):274-9. PubMed ID: 2866235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between the use of anticholinergic antiparkinson drugs and safety and receptor drug-binding profiles of antipsychotic agents.
    Gjerden P; Slørdal L; Bramness JG
    Eur J Clin Pharmacol; 2009 Dec; 65(12):1229-35. PubMed ID: 19644682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroleptic affinities for human brain receptors and their use in predicting adverse effects.
    Richelson E
    J Clin Psychiatry; 1984 Aug; 45(8):331-6. PubMed ID: 6146602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum neuroleptic levels and extrapyramidal side effects in patients treated with amoxapine.
    Gaffney GR; Tune LE
    J Clin Psychiatry; 1985 Oct; 46(10):428-9. PubMed ID: 2864332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the affinity constant of some muscarinic receptor antagonists with their displacement of [3H]quinuclidinyl benzilate binding in atrial and ileal longitudinal muscle of the guinea-pig.
    Choo LK; Mitchelson FJ
    J Pharm Pharmacol; 1985 Sep; 37(9):656-8. PubMed ID: 2867189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum levels of anticholinergic drugs and impaired recent memory in chronic schizophrenic patients.
    Tune LE; Strauss ME; Lew MF; Breitlinger E; Coyle JT
    Am J Psychiatry; 1982 Nov; 139(11):1460-2. PubMed ID: 6127957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pupillometry and radioreceptor binding. Semeiologic suggestions in the evaluation of the treatment with anticholinergic drugs.
    Micieli G; Flauto C; Magri M; Vescovi A; Cavallini A; Parati E
    Arzneimittelforschung; 1990 Jun; 40(6):647-50. PubMed ID: 2396998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anticholinergic delirium caused by topical homatropine ophthalmologic solution: confirmation by anticholinergic radioreceptor assay in two cases.
    Tune LE; Bylsma FW; Hilt DC
    J Neuropsychiatry Clin Neurosci; 1992; 4(2):195-7. PubMed ID: 1627983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of postoperative delirium with raised serum levels of anticholinergic drugs.
    Tune LE; Damlouji NF; Holland A; Gardner TJ; Folstein MF; Coyle JT
    Lancet; 1981 Sep; 2(8248):651-3. PubMed ID: 6116042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of [3H]pirenzepine binding to muscarinic cholinergic receptors solubilized from rat brain.
    Luthin GR; Wolfe BB
    J Pharmacol Exp Ther; 1985 Jul; 234(1):37-44. PubMed ID: 3839265
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain.
    Ehlert FJ; Tran LP
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1148-57. PubMed ID: 2262898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anticholinergic agents for prophylaxis of neuroleptic-induced dystonic reactions: a prospective study.
    Sramek JJ; Simpson GM; Morrison RL; Heiser JF
    J Clin Psychiatry; 1986 Jun; 47(6):305-9. PubMed ID: 2872206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Muscarinic receptor binding in the parotid gland. Different affinities of some anticholinergic drugs between the parotid gland and ileum.
    Nilvebrant L; Sparf B
    Scand J Gastroenterol Suppl; 1982; 72():69-77. PubMed ID: 6957999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.